← Eichor
Study identifier: NCT00082108 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

Condition: Myotonic Dystrophy · Facioscapulohumeral Muscular Dystrophy · Muscular Dystrophy  ·  Sponsor: University of Rochester

PhaseN/A
Planned participants3000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

Myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD) are inherited disorders characterized by progressive muscle weakness and loss of muscle tissue. The purpose of this registry is to connect people with DM or FSHD with researchers studying these diseases. The registry will offer individuals with DM and FSHD an opportunity to participate in research that focuses of their diseases. The registry will also help scientists to accomplish research on DM and FSHD and to distribute their findings to patients and care providers.

This description comes directly from the study's public registry record.

Talk to the study team

Registry Coordinator  ·  888-925-4302  ·  dystrophy_registry@urmc.rochester.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Rochester Medical Center, Department of NeurologyRochester, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT00082108